International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer

Erstveröffentlichung

2022

Authors

Novello, Sergio B.

Torri, Vamsee

Grohe, Christian

Kurz, Sarah

Serke, Monika

et al.

Wissenschaftlicher Artikel

Published in

Annals of Oncology ; 33 (2022), 1. - S. 57-66. - ISSN 0923-7534. - eISSN 1569-8041

Link to publication

https://dx.doi.org/10.1016/j.annonc.2021.09.017

Institutions

UKU. Klinik für Innere Medizin II

Subject headings

[Free subject headings]: non-small-cell lung cancer | adjuvant chemotherapy | pharmacogenomics | excision repair cross-complementation 1 | thymidylate synthase | messenger RNA | MESSENGER-RNA LEVELS | PROTEIN EXPRESSION | ERCC1 | CISPLATIN | SURVIVAL | REPAIR | RRM1 | THERAPY
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record